KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Assets Average (2019 - 2025)

BioNTech SE's Assets Average history spans 7 years, with the latest figure at $25.3 billion for Q4 2025.

  • On a quarterly basis, Assets Average rose 3.84% to $25.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $25.3 billion, a 3.84% increase, with the full-year FY2025 number at $24.5 billion, changed 0.18% from a year prior.
  • Assets Average hit $25.3 billion in Q4 2025 for BioNTech SE, up from $24.7 billion in the prior quarter.
  • Over the last five years, Assets Average for BNTX hit a ceiling of $25.3 billion in Q4 2025 and a floor of $3.9 billion in Q1 2021.
  • Historically, Assets Average has averaged $21.1 billion across 5 years, with a median of $23.6 billion in 2023.
  • Biggest five-year swings in Assets Average: surged 905.48% in 2021 and later dropped 5.26% in 2025.
  • Tracing BNTX's Assets Average over 5 years: stood at $17.4 billion in 2021, then surged by 33.54% to $23.3 billion in 2022, then increased by 5.0% to $24.5 billion in 2023, then decreased by 0.51% to $24.3 billion in 2024, then increased by 3.84% to $25.3 billion in 2025.
  • Business Quant data shows Assets Average for BNTX at $25.3 billion in Q4 2025, $24.7 billion in Q3 2025, and $23.4 billion in Q2 2025.